QUEST DIAGNOSTICS INC. news, videos and press releases - Page 4
For more news please use our advanced search feature.
QUEST DIAGNOSTICS INC. - More news...
QUEST DIAGNOSTICS INC. - More news...
- My Quest Story - Pauline Chaves
- She Is Not Skipping a Beat, and Patients Are Noticing
- Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
- My Quest Story - Eddy Hurst
- Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
- Quest Colleague Is Exhibiting Care for Every Patient in Her Chair
- Phlebotomist's Actions Keep One Patient Coming Back
- My Quest Story - Allan Mendez
- First PFAS "Forever Chemicals" Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com
- On Rare Disease Day, Q4HE Collaboration Highlights Purpose in Action
- Ten Years Running: FORTUNE Names Quest Diagnostics One of 2024 "World's Most Admired Companies"
- Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
- Living Our Purpose - Ivelisse Lugo
- Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery
- Quest Diagnostics and Instacart Collaborate To Reduce Food Insecurity Across the United States With Integrated Patient Health Coaching and Nutritious Grocery Delivery
- Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery
- First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
- Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
- Ten Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies"
- Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health
- Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma
- Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024
- Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health
- Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System
- No-Cost Testing Helps Bolster I-HEAL Community Wellness Day in Mississippi Delta Region
- Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
- Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer
- Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel
- Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
- Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation’s Corporate Equality Index for Seventh Consecutive Year
